Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

BACKGROUND: Diffuse myocardial fibrosis is a final end point in most cardiac diseases. It is missed by the cardiovascular magnetic resonance (CMR) late gadolinium enhancement technique. Currently, quantifying diffuse myocardial fibrosis requires invasive biopsy, with inherent risk and sampling error...

Full description

Bibliographic Details

Published in:	Circulation Vol. 122; no. 2; pp. 138 - 145
Main Authors:	Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC
Format:	clinical trial research Journal Article
Published:	Lippincott Williams & Wilkins 7/13/2010
Online Access:	View this record in EBSCOhost